4//SEC Filing
SCHWARTZ MARK W. 4
Accession 0001422882-12-000004
CIK 0001390478other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:39 PM ET
Size
5.7 KB
Accession
0001422882-12-000004
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2012-01-12+200,000→ 200,000 totalExercise: $0.72Exp: 2022-01-12→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Issuer's 2007 Incentive Plan.
- [F2]The options will vest in equal quarterly installments of 12,500 shares for four years beginning on April 12, 2012, with all such options being fully vested on January 12, 2016.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001422882
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:39 PM ET
- Size
- 5.7 KB